Showing results (1-10 of 63) with videos related to
Sort By:
Pageof 7
Acta Oto-Laryngologica|May 30, 2009
No hearing loss after repeated courses of tobramycin in cystic fibrosis patientsRenske J Scheenstra, Harry G M Heijerman, Charlotte L Zuur, et al.Cancer Medicine|August 19, 2024
The role of genetic variants in the prediction of hearing loss due to cisplatin chemoradiotherapyCharlotte W Duinkerken, Sabrina Chiodo, Katrina Hueniken, et al.International Journal of Radiation Oncology, Biology, Physics|January 13, 2009
Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and-neck tumorsCharlotte L Zuur, Yvonne J Simis, Emmy A Lamers, et al.European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|October 12, 2019
Disease course after the first recurrence of head and neck squamous cell carcinoma following (chemo)radiationMischa de Ridder, Pieter D de Veij Mestdagh, Joris B W Elbers, et al.Cancers|September 8, 2015
Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative ReviewAmy J C Dohmen, Justin E Swartz, Michiel W M Van Den Brekel, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2008
Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancerCharlotte L Zuur, Yvonne J W Simis, Roxanna S Verkaik, et al.International Journal of Radiation Oncology, Biology, Physics|April 10, 2007
Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysisCharlotte L Zuur, Yvonne J Simis, Pauline E Lansdaal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancerCharlotte L Zuur, Yvonne J Simis, Pauline E Lansdaal, et al.Oncotarget|June 5, 2018
Sponge-supported cultures of primary head and neck tumors for an optimized preclinical modelAmy J C Dohmen, Joyce Sanders, Sander Canisius, et al.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|May 8, 2019
Organ Function Preservation Failure after (Chemo)Radiotherapy in Head and Neck Cancer: A Retrospective Cohort AnalysisJolien Heukelom, Arash Navran, Zeno A R Gouw, et al.Pageof 7